In accordance with Article 3.5.3 of the Tennis Anti-Doping Programme (TADP), if a Player has a TUE granted by his/her National Anti-Doping Organisation (NADO) that he/she wishes to have recognised by the ITF for the purposes of the Programme, the Player should apply to the TUE Committee for recognition of the TUE (through the online TUE Portal), in accordance with the procedure set out in Article 7 of the International Standard for Therapeutic Use Exemptions.
The request must be accompanied by all of the information specified in Article 7 of the International Standard for Therapeutic Use Exemptions, and the TUE Committee may require that further information be provided as necessary. Unless and until such recognition is granted in writing, the Player uses the Prohibited Substance or Prohibited Method in issue entirely at his/her own risk
Under TADP Article 3.5.4, if the TUE Committee agrees that the TUE granted to the Player by his/her NADO meets the criteria set out in the International Standard for Therapeutic Use Exemptions, then the ITF shall recognise it. If the TUE Committee considers that the TUE does not meet those criteria and so refuses to recognise it, the Player shall be notified and shall have 21 days from such notification to refer the matter to WADA for review. If the matter is referred to WADA for review, the TUE granted by the NADO remains valid for national-level Competition and Out-of-Competition Testing (but is not valid for Covered Events under the TADP) pending WADA's decision. If the matter is not referred to WADA for review, the TUE becomes invalid for any purpose upon expiry of the 21-day review deadline.